Analyst Ratings for Vir Biotechnology (VIR)
VIR Rating Summary
VIR Price Target Summary
- Highest: $110.00 (H.C. Wainwright)
- Lowest: $10.00 (JPMorgan)
- Average: $31.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$31.50 (+281.8%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$31.50 (+281.8%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2024 | JPMorgan » Updated 2/23/2024 |
Eric Joseph | Downgrade | Neutral (Overweight) |
10.00 (9.00) |
9.70 (8.25) |
-14.95% | Details |
| 9/8/2023 | BofA Securities | Geoff Meacham | Downgrade | Neutral (Buy) |
14.00 (23.00) |
11.56 (8.25) |
-28.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
